Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05510908 · ClinicalTrials.gov registry record
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 460
- Enrollment target
NCT05510908 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 460 participants.
The verdict
NCT05510908 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 460 participants
- Enrollment target
Study Summary
This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.
Interventions
- OTHER Non-Interventional
- OTHER Non-Interventional Follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2025-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05510908
The ClinicalTrials.gov registry entry for NCT05510908 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-Interventional is the first listed.
NCT05510908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05510908 about?
NCT05510908 is a clinical study titled "Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC". This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to le...
What is the current status of trial NCT05510908?
This trial is currently completed. The enrollment target is 460 participants. The study started on 2023-07-25. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT05510908?
The interventions under investigation include: Non-Interventional (OTHER), Non-Interventional Follow-up (OTHER).
Who is sponsoring clinical trial NCT05510908?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.